January 10, 2022 by Jeffrey Woldt
CVS, CVS Health, Karen Lynch
January 10, 2022, Opinion
As Karen Lynch nears the end of her first year as president and chief executive officer of CVS Health, it’s clear that she is intent on extending the legacy of growth and innovation that has been a hallmark of the company for more than three decades. Speaking at CVS’ investor day in New York City
December 22, 2021 by Chain Drug Review
COVID testing, CVS, Walgreens
Leading Headlines, Pharmacy, Retail News
NEW YORK —As the omicron variant continues to spread throughout the U.S. and COVID-19 cases spike ahead of Christmas, demand for at-home testing kits has risen dramatically. This has prompted Amazon, Walgreens and CVS this week to limit how many tests each customer can purchase. Amazon said it won’t let individual shoppers buy more than
December 6, 2021 by David Pinto
CVS
December 6, 2021, Opinion
What’s going on at CVS? Are these dramatic moves that were announced recently by the Woonsocket, R.I.-based drug chain the preface to a new beginning or an admission that all is not running as smoothly as the chain drug industry and one of its premier retailers had hoped? That’s the question most on industry minds
November 23, 2021 by Chain Drug Review
CVS, Jurors in Cleveland federal court after six days of deliberations concluded that actions by the pharmacy chains, Opioid trial, Walgreens
Leading Headlines, Pharmacy
CLEVELAND — A federal jury on Tuesday found that pharmacies operated by CVS Health, Walgreens and Walmart contributed to the opioid epidemic in two Ohio counties, Reuters reported. The trial was for a lawsuit filed in 2018 by Ohio’s Lake and Trumbull counties against Giant Eagle, Walgreens Boots Alliance, CVS Health and Walmart. Thousands of
October 22, 2021 by Chain Drug Review
CVS, Hy-Vee, Moderna and J&J vaccine boosters, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News
NEW YORK — The Centers for Disease Control and Prevention formally recommended booster shots for many recipients of Moderna and Johnson & Johnson’s vaccines. As a result, up to 99 million Americans are now eligible for additional doses bolstering protection against COVID-19 beginning Friday. This follows FDA authorization of a Pfizer booster dose on Sept.
October 4, 2021 by Jeffrey Woldt
COVID-19, CVS, Karen Lynch
October 4, 2021, Opinion
An article in a recent edition of The Wall Street Journal about challenges caused by a shortfall of workers at CVS Health missed the forest for the trees, focusing on problems at a few of its more than 10,000 drug stores, while giving short shrift to the extraordinary contributions that CVS — like other retail
September 17, 2021 by Chain Drug Review
CVS, Novo Nordisk
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health and Novo Nordisk Inc. announced today that the two companies are piloting a new, personalized nutrition coaching program to support people struggling with obesity, after their treatment plan has been determined by a licensed provider. More than 40 percent of the U.S. population suffers from obesity, a chronic disease that
August 9, 2021 by David Pinto
CVS, David Pinto, Walgreens
August 9, 2021, Opinion
One could argue, with some degree of logic and certainty, that the most intriguing and significant competition in today’s mass retail community is the duel between Walmart and Amazon. Certainly the stakes are high — with the two retailers occupying the very top rungs of the retail ladder. Then, too, each approaches the market in
August 4, 2021 by Chain Drug Review
CVS, earnings, Lynch, minimum wage, second quarter
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health posted second quarter sales and earnings that easily topped analysts’ projections. Strong retail sales helped lift the company’s adjusted profit to $2.42 a share, well ahead of Wall Street’s prediction of $2.07 a share. Revenue climbed 11.1% to $72.62 billion, beating the forecast of $70.24 billion. The company boosted its
July 22, 2021 by Chain Drug Review
Bernstein, Bluemercury, CVS
Leading Headlines, Retail News
NEW YORK — Former CVS Health executive Maly Bernstein has been named chief executive officer of Bluemercury, a Macy’s Inc. retail brand, effective September 13. She will oversee the growth and strategy of all aspects of Bluemercury, from its digital platform to stores. She will report to Tony Spring, chairman and CEO of Bloomingdale’s, and
July 12, 2021 by Chain Drug Review
CVS, purpose statement
Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health on Monday issued the following statement about the evolution of its purpose statement. “Over the past several years, we’ve seen the power of being a purpose-driven company and how it can keep all our colleagues — from the C-suite to the front line — focused on our customers’ needs and
July 9, 2021 by Chain Drug Review
CVS, Intermountain Healthcare
Leading Headlines
SALT LAKE CITY, Utah — CVS next month will acquire the prescription files of 25 Utah pharmacies being closed by Intermountain Healthcare. CVS Pharmacy is working closely with the healthcare system to ensure the transition is seamless for patients and that their access to pharmacy care is uninterrupted. Pharmacy files of each location will be
June 18, 2021 by Chain Drug Review
Coleman, CVS
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS Health senior vice president of merchandising George Coleman is leaving the company early next month to be with his wife in Italy. “It’s not an easy decision, but it’s a decision driven by my heart,” Coleman wrote in a letter to suppliers. “Many of you are familiar with my story. Three
May 18, 2021 by Chain Drug Review
CVS, Hy-Vee, Mask policy, Target
Leading Headlines, Retail News
NEW YORK — More retailers are joining the list of stores dropping mask requirements for customers and employees if they’re fully vaccinated against COVID-19. CVS Pharmacy announced that, consistent with the latest CDC guidance, effective May 17 customers who are fully vaccinated are no longer required to wear face coverings inside of our stores, unless it